Optimal treatment of leptospirosis: queries and projections

Antonio Cascio, Antonio Cascio, Georgios Pappas

Risultato della ricerca: Articlepeer review

36 Citazioni (Scopus)


Although the global burden of leptospirosis remains enormous and new aspects of the disease are constantly recognised, little progress has been achieved in the field of leptospirosis therapeutics and queries regarding the utility of antibiotics in the late severe form of the disease remain. From the currently existing data, conclusions on the efficacy of antibiotic administration in severe or late disease cannot easily be drawn, since clinical trials have different selection criteria and may focus on Leptospira serovars with different virulence. However, as a rule the benefit of the doubt should apply. Moreover, new options, such as ceftriaxone, have a superior safety profile to penicillin. In vitro studies have outlined potential antimicrobial candidates such as macrolides and ketolides. Development of a globally accepted subunit vaccine for humans is warranted but is not expected in the near future
Lingua originaleEnglish
pagine (da-a)491-496
Numero di pagine6
RivistaInternational Journal of Antimicrobial Agents
Stato di pubblicazionePublished - 2006

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Entra nei temi di ricerca di 'Optimal treatment of leptospirosis: queries and projections'. Insieme formano una fingerprint unica.

Cita questo